Johannes Wohlrab (J Wohlrab)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 8

Top Topics

Combination Therapy

Top Venues

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG

Journal of the European Academy of Dermatology and Venereology : JEADV

This page only lists publications with an associated author ORCID identifier.

Publications

Linda Golle, Cord Sunderkoetter, Jovine Ehrenreich, Johannes Wohlrab
Successful treatment of complex cutaneous leishmaniasis (L. tropica) in a 3-year-old Syrian boy with miltefosine. Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG 22 (8) (2024)
Albert Narwutsch, Johannes Wohlrab, Anne-D Sperfeld, Cord Sunderkoetter
Combination therapy for Sneddon syndrome to reduce the incidence of cerebrovascular complications. Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG 22 (7) (2024)
Linda Golle, Cord Sunderkoetter, Jovine Ehrenreich, Johannes Wohlrab
Successful treatment of complex cutaneous leishmaniasis (L. tropica) in a 3-year-old Syrian boy with miltefosine. Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG (2024)
Tom Bruns, Cord Sunderkoetter, Johannes Wohlrab
Intravenous treatment of calcinosis cutis with sodium thiosulfate - A case series. Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG (2024)
Linda Golle, Cord Sunderkoetter, Jovine Ehrenreich, Johannes Wohlrab
Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG 22 (8) (2024)
Albert Narwutsch, Johannes Wohlrab, Anne-D Sperfeld, Cord Sunderkoetter
Combination therapy for Sneddon syndrome to reduce the incidence of cerebrovascular complications. Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG 22 (7) (2024)
Enrico Fusaro, Patrick Durez, Johannes Wohlrab, Soohyun Lee, Sangwook Yoon, Hubert Marotte
An update on the adalimumab biosimilar landscape following the approval of the first high-concentration biosimilar. Immunotherapy (2021)
Johannes Wohlrab, T Werfel, Andreas Wollenberg
Pathomechanism of dupilumab-associated inflammatory eye symptoms. Journal of the European Academy of Dermatology and Venereology : JEADV 33 (11) (2019)